The trick to getting this center going will be to get a few good startups hatched fast, so that venture capitalists and Big Pharma will start to see it as a go-to place for new compounds.
Wiberg of ATV acknowledges the idea then consisted mostly of old research and a big potential market but says he bet on the team's ability to get results fast.